Newsletter: Weekly FDA Review (11/19/2009) - Subscribe/Unsubscribe


PharmacyOneSource.comWeekly FDA Review - 19.November.2009
  1. Final Approvals (4)
  2. Rejections (2)
  3. Orphan Drug Designations (0)
  4. Recommended Approvals (1)
  5. Fast Track Status (0)
  6. Complete Response Letters (2)
  7. Tentative Approvals (1)
  8. Priority Reviews (1)
  9. New Drug Applications (1)
  10. Alerts, Recalls and Shortages (3)

Sentri7 monitors anticoagulation patients to help you comply with The Joint Commission's NPSG 3E. Get a demo.
1. Final Approvals
  1. Qutenza Approved for Post-Shingles Nerve Pain
    HealthDay
  2. Glenmark Generics gets FDA nod for Ciclopirox Olamine
    Business Standard
  3. Par Pharma gets FDA approval for generic Ultram ER
    Associated Press
  4. FDA Approves Lysteda To Treat Heavy Menstrual Bleeding
    Medical News Today
2. Rejections
  1. Genzyme's Pompe drug rejected
    Reuters
  2. CombinatoRx dives on FDA rejection
    Bloomberg News
4. Recommended Approvals
  1. FDA panel OKs new kids' pneumococcal shot
    Associated Press
6. Complete Response Letters
  1. Genentech, Biogen get FDA request on Rituxan
    Associated Press
  2. HGS's anthrax drug delayed by FDA
    Washington Post
7. Tentative Approvals
  1. Sun Pharma wins FDA tentative approval for generic leukemia drug
    Trading Markets
8. Priority Reviews
  1. FDA to review Actelion's Zavesca for additional use
    Reuters
9. New Drug Applications
  1. AstraZeneca asks for U.S. approval of Brilinta
    Reuters
10. Alerts, Recalls and Shortages
  1. ALERT: Clopidogrel
    FDA Notice
  2. ALERT: Genzyme
    FDA Notice
  3. Alert: Local Anesthetics
    FDA Notice

E-mail This Newsletter to a Friend

PharmacyOneSource.com Privacy Policy
Pharmacy OneSource, 7780 Elmwood Ave. Ste #210 Middleton, WI 53562
Phone: (800) 654-8395


 


<< Back

 
statistics_tracker